The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1795, Issue 1, 2009, Pages 37-52

  Acquaviva, Jaime ^a   Wong, Ricky ^a   Charest, Al ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

c ROS; Cancer; Glioblastoma; Kinase; Receptor; Signal Transduction

Indexed keywords

CD74 ROS FUSION PROTEIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SH2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE KINASE ROS; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAPAMYCIN; SLC34A2 ROS FUSION PROTEIN; SODIUM PHOSPHATE COTRANSPORTER 2B; STAT3 PROTEIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VAV PROTEIN; VAV3 PROTEIN;

BRAIN CANCER; BREAST CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME REARRANGEMENT; COLON CANCER; DRUG TARGETING; EPITHELIUM CELL; GENE EXPRESSION; GENE ISOLATION; GENETIC VARIABILITY; GENITAL SYSTEM; GLIOBLASTOMA; HEART DISEASE; HUMAN; INTESTINE; KIDNEY; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; NONHUMAN; ONCOGENE; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; EVOLUTION, MOLECULAR; GROWTH AND DEVELOPMENT; HUMANS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 58049170380     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2008.07.006     Document Type: Review

References (177)

1. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
2. Hubbard S.R., and Miller W.T. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr. Opin. Cell Biol. 19 (2007) 117-123
3. Balduzzi P.C., Notter M.F., Morgan H.R., and Shibuya M. Some biological properties of two new avian sarcoma viruses. J. Virol. 40 (1981) 268-275
4. Shibuya M., Hanafusa H., and Balduzzi P.C. Cellular sequences related to three new onc genes of avian sarcoma virus (fps, yes, and ros) and their expression in normal and transformed cells. J. Virol. 42 (1982) 143-152
5. Wang L.H., Hanafusa H., Notter M.F., and Balduzzi P.C. Genetic structure and transforming sequence of avian sarcoma virus UR2. J. Virol. 41 (1982) 833-841
6. Feldman R.A., Wang L.H., Hanafusa H., and Balduzzi P.C. Avian sarcoma virus UR2 encodes a transforming protein which is associated with a unique protein kinase activity. J. Virol. 42 (1982) 228-236
7. Macara I.G., Marinetti G.V., and Balduzzi P.C. Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 2728-2732
8. Neckameyer W.S., and Wang L.H. Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses. J. Virol. 50 (1984) 914-921
9. Notter M.F., and Balduzzi P.C. Cytoskeletal changes induced by two avian sarcoma viruses: UR2 and Rous sarcoma virus. Virology 136 (1984) 56-68
10. Notter M.F., Navon S.E., Fung B.K., and Balduzzi P.C. Infection of neuroretinal cells in vitro by avian sarcoma viruses UR1 and UR2: transformation, cell growth stimulation, and changes in transducin levels. Virology 160 (1987) 489-493
11. Maytin E.V., Balduzzi P.C., Notter M.F., and Young D.A. Changes in the synthesis and phosphorylation of cellular proteins in chick fibroblasts transformed by two avian sarcoma viruses. J. Biol. Chem. 259 (1984) 12135-12143
12. Neckameyer W.S., and Wang L.H. Nucleotide sequence of avian sarcoma virus UR2 and comparison of its transforming gene with other members of the tyrosine protein kinase oncogene family. J. Virol. 53 (1985) 879-884
13. Fasano O., Birnbaum D., Edlund L., Fogh J., and Wigler M. New human transforming genes detected by a tumorigenicity assay. Mol. Cell Biol. 4 (1984) 1695-1705
14. Birchmeier C., Birnbaum D., Waitches G., Fasano O., and Wigler M. Characterization of an activated human ros gene. Mol. Cell Biol. 6 (1986) 3109-3116
15. Shibuya M., Matsushime H., Yamazaki H., Wang L.H., Fukui Y., Ueyama Y., and Tamaoki N. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes. Princess Takamatsu Symp. 17 (1986) 195-202
16. Matsushime H., Wang L.H., and Shibuya M. Human c-ros-1 gene homologous to the v-ros sequence of UR2 sarcoma virus encodes for a transmembrane receptorlike molecule. Mol. Cell Biol. 6 (1986) 3000-3004
17. Neckameyer W.S., Shibuya M., Hsu M.T., and Wang L.H. Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue specific and developmentally regulated expression. Mol. Cell Biol. 6 (1986) 1478-1486
18. Podell S.B., and Sefton B.M. Chicken proto-oncogene c-ros cDNA clones: identification of a c-ros RNA transcript and deduction of the amino acid sequence of the carboxyl terminus of the c-ros product. Oncogene 2 (1987) 9-14
19. Wang L.H., and Hanafusa H. Avian sarcoma viruses. Virus. Res. 9 (1988) 159-203
20. Birchmeier C., O'Neill K., Riggs M., and Wigler M. Characterization of ROS1 cDNA from a human glioblastoma cell line. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4799-4803
21. Das K.S., Christensen J.R., and Balduzzi P.C. Transfection and recombination with molecularly cloned derivatives of avian sarcoma virus UR2. Virology 154 (1986) 415-419
22. Jong S.M., and Wang L.H. Role of gag sequence in the biochemical properties and transforming activity of the avian sarcoma virus UR2-encoded gag-ros fusion protein. J. Virol. 64 (1990) 5997-6009
23. Jong S.M., and Wang L.H. Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association. J. Virol. 65 (1991) 180-189
24. Jong S.M., Zong C.S., Dorai T., and Wang L.H. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants. J. Virol. 66 (1992) 4909-4918
25. Yao R., Maeda T., Takada S., and Noda T. Identification of a PDZ domain containing Golgi protein, GOPC, as an interaction partner of frizzled. Biochem. Biophys. Res. Commun. 286 (2001) 771-778
26. Neudauer C.L., Joberty G., and Macara I.G. PIST: a novel PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10. Biochem. Biophys. Res. Commun. 280 (2001) 541-547
27. Cheng J., Moyer B.D., Milewski M., Loffing J., Ikeda M., Mickle J.E., Cutting G.R., Li M., Stanton B.A., and Guggino W.B. A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J. Biol. Chem. 277 (2002) 3520-3529
28. Charest A., Kheifets V., Park J., Lane K., McMahon K., Nutt C.L., and Housman D. Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 916-921
29. Charest A., Lane K., McMahon K., and Housman D.E. Association of a novel PDZ domain-containing peripheral Golgi protein with the Q-SNARE (Q-soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor) protein syntaxin 6. J. Biol. Chem. 276 (2001) 29456-29465
30. Charest A., Lane K., McMahon K., Park J., Preisinger E., Conroy H., and Housman D. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21). Genes Chromosomes Cancer 37 (2003) 58-71
31. Charest A., Wilker E.W., McLaughlin M.E., Lane K., Gowda R., Coven S., McMahon K., Kovach S., Feng Y., Yaffe M.B., Jacks T., and Housman D. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Cancer Res. 66 (2006) 7473-7481
32. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.L., Polakiewicz R.D., Rush J., and Comb M.J. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131 (2007) 1190-1203
33. Matsushime H., and Shibuya M. Tissue-specific expression of rat c-ros-1 gene and partial structural similarity of its predicted products with sev protein of Drosophila melanogaster. J. Virol. 64 (1990) 2117-2125
34. Chen J.M., Heller D., Poon B., Kang L., and Wang L.H. The proto-oncogene c-ros codes for a transmembrane tyrosine protein kinase sharing sequence and structural homology with sevenless protein of Drosophila melanogaster. Oncogene 6 (1991) 257-264
35. Robinson D.R., Wu Y.M., and Lin S.F. The protein tyrosine kinase family of the human genome. Oncogene 19 (2000) 5548-5557
36. Ruoslahti E. Fibronectin and its receptors. Annu. Rev. Biochem. 57 (1988) 375-413
37. McKern N.M., Lawrence M.C., Streltsov V.A., Lou M.Z., Adams T.E., Lovrecz G.O., Elleman T.C., Richards K.M., Bentley J.D., Pilling P.A., Hoyne P.A., Cartledge K.A., Pham T.M., Lewis J.L., Sankovich S.E., Stoichevska V., Da Silva E., Robinson C.P., Frenkel M.J., Sparrow L.G., Fernley R.T., Epa V.C., and Ward C.W. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 443 (2006) 218-221
38. Ward C., Lawrence M., Streltsov V., Garrett T., McKern N., Lou M.Z., Lovrecz G., and Adams T. Structural insights into ligand-induced activation of the insulin receptor. Acta. Physiol. (Oxf) 192 (2008) 3-9
39. Carvalho R.F., Beutler M., Marler K.J., Knoll B., Becker-Barroso E., Heintzmann R., Ng T., and Drescher U. Silencing of EphA3 through a cis interaction with ephrinA5. Nat. Neurosci. 9 (2006) 322-330
40. Riethmacher D., Langholz O., Godecke S., Sachs M., and Birchmeier C. Biochemical and functional characterization of the murine ros protooncogene. Oncogene 9 (1994) 3617-3626
41. Kanwar Y.S., Liu Z.Z., Kumar A., Wada J., and Carone F.A. Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins. Kidney Int. 48 (1995) 1646-1659
42. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
43. Page A.P., and Johnstone I.L. The cuticle. WormBook (2007) 1-15
44. Cox G.N., Laufer J.S., Kusch M., and Edgar R.S. Genetic and phenotypic characterization of roller mutants of Caenorhabditis elegans. Genetics 95 (1980) 317-339
45. Barbazuk W.B., Johnsen R.C., and Baillie D.L. The generation and genetic analysis of suppressors of lethal mutations in the Caenorhabditis elegans rol-3(V) gene. Genetics 136 (1994) 129-143
46. Hunt-Newbury R., Viveiros R., Johnsen R., Mah A., Anastas D., Fang L., Halfnight E., Lee D., Lin J., Lorch A., McKay S., Okada H.M., Pan J., Schulz A.K., Tu D., Wong K., Zhao Z., Alexeyenko A., Burglin T., Sonnhammer E., Schnabel R., Jones S.J., Marra M.A., Baillie D.L., and Moerman D.G. High-throughput in vivo analysis of gene expression in Caenorhabditis elegans. PLoS Biol. 5 (2007) e237
47. Hafen E., Basler K., Edstroem J.E., and Rubin G.M. Sevenless, a cell-specific homeotic gene of Drosophila, encodes a putative transmembrane receptor with a tyrosine kinase domain. Science 236 (1987) 55-63
48. Price J.V., Clifford R.J., and Schupbach T. The maternal ventralizing locus torpedo is allelic to faint little ball, an embryonic lethal, and encodes the Drosophila EGF receptor homolog. Cell 56 (1989) 1085-1092
49. Schejter E.D., and Shilo B.Z. The Drosophila EGF receptor homolog (DER) gene is allelic to faint little ball, a locus essential for embryonic development. Cell 56 (1989) 1093-1104
50. Bergmann A., Agapite J., McCall K., and Steller H. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell 95 (1998) 331-341
51. Freeman M. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell 87 (1996) 651-660
52. Kumar J.P., Tio M., Hsiung F., Akopyan S., Gabay L., Seger R., Shilo B.Z., and Moses K. Dissecting the roles of the Drosophila EGF receptor in eye development and MAP kinase activation. Development 125 (1998) 3875-3885
53. Kurada P., and White K. Ras promotes cell survival in Drosophila by downregulating hid expression. Cell 95 (1998) 319-329
54. Spencer S.A., Powell P.A., Miller D.T., and Cagan R.L. Regulation of EGF receptor signaling establishes pattern across the developing Drosophila retina. Development 125 (1998) 4777-4790
55. Xu T., and Rubin G.M. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117 (1993) 1223-1237
56. Tomlinson A., and Ready D.F. Sevenless: a cell-specific homeotic mutation of the drosophila eye. Science 231 (1986) 400-402
57. Raabe T. The sevenless signaling pathway: variations of a common theme. Biochim. Biophys. Acta. 1496 (2000) 151-163
58. Hart A.C., Kramer H., Van Vactor Jr. D.L., Paidhungat M., and Zipursky S.L. Induction of cell fate in the Drosophila retina: the bride of sevenless protein is predicted to contain a large extracellular domain and seven transmembrane segments. Genes Dev. 4 (1990) 1835-1847
59. Kramer H., Cagan R.L., and Zipursky S.L. Interaction of bride of sevenless membrane-bound ligand and the sevenless tyrosine-kinase receptor. Nature 352 (1991) 207-212
60. Reinke R., and Zipursky S.L. Cell-cell interaction in the Drosophila retina: the bride of sevenless gene is required in photoreceptor cell R8 for R7 cell development. Cell 55 (1988) 321-330
61. Chen J., Zong C.S., and Wang L.H. Tissue and epithelial cell-specific expression of chicken proto-oncogene c-ros in several organs suggests that it may play roles in their development and mature functions. Oncogene 9 (1994) 773-780
62. Sonnenberg E., Godecke A., Walter B., Bladt F., and Birchmeier C. Transient and locally restricted expression of the ros1 protooncogene during mouse development. Embo. J. 10 (1991) 3693-3702
63. Tessarollo L., Nagarajan L., and Parada L.F. c-ros: the vertebrate homolog of the sevenless tyrosine kinase receptor is tightly regulated during organogenesis in mouse embryonic development. Development 115 (1992) 11-20
64. Saxen L. Organogenesis of the Kidney (1987), Cambridge University Press, Cambridge
65. Liu Z.Z., Wada J., Kumar A., Carone F.A., Takahashi M., and Kanwar Y.S. Comparative role of phosphotyrosine kinase domains of c-ros and c-ret protooncogenes in metanephric development with respect to growth factors and matrix morphogens. Dev. Biol. 178 (1996) 133-148
66. Eddy E.M. Male germ cell gene expression. Recent Prog. Horm. Res. 57 (2002) 103-128
67. Sonnenberg-Riethmacher E., Walter B., Riethmacher D., Godecke S., and Birchmeier C. The c-ros tyrosine kinase receptor controls regionalization and differentiation of epithelial cells in the epididymis. Genes Dev. 10 (1996) 1184-1193
68. Legare C., and Sullivan R. Expression and localization of c-ros oncogene along the human excurrent duct. Mol. Hum. Reprod. 10 (2004) 697-703
69. Shyamsundar R., Kim Y.H., Higgins J.P., Montgomery K., Jorden M., Sethuraman A., van de Rijn M., Botstein D., Brown P.O., and Pollack J.R. A DNA microarray survey of gene expression in normal human tissues. Genome. Biol. 6 (2005) R22
70. Birchmeier C., Sharma S., and Wigler M. Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 9270-9274
71. Mapstone T., McMichael M., and Goldthwait D. Expression of platelet-derived growth factors, transforming growth factors, and the ros gene in a variety of primary human brain tumors. Neurosurgery 28 (1991) 216-222
72. Watkins D., Dion F., Poisson M., Delattre J.Y., and Rouleau G.A. Analysis of oncogene expression in primary human gliomas: evidence for increased expression of the ros oncogene. Cancer Genet. Cytogenet. 72 (1994) 130-136
73. Zhao J.F., and Sharma S. Expression of the ROS1 oncogene for tyrosine receptor kinase in adult human meningiomas. Cancer Genet. Cytogenet. 83 (1995) 148-154
74. Girish V., Sachdeva N., Minz R.W., Radotra B., Mathuria S.N., and Arora S.K. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype. Indian J. Pathol. Microbiol. 48 (2005) 325-330
75. Bonner A.E., Lemon W.J., Devereux T.R., Lubet R.A., and You M. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene 23 (2004) 1166-1176
76. Sweet-Cordero A., Mukherjee S., Subramanian A., You H., Roix J.J., Ladd-Acosta C., Mesirov J., Golub T.R., and Jacks T. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat. Genet. 37 (2005) 48-55
77. Sweet-Cordero A., Tseng G.C., You H., Douglass M., Huey B., Albertson D., and Jacks T. Comparison of gene expression and DNA copy number changes in a murine model of lung cancer. Genes Chromosomes Cancer 45 (2006) 338-348
78. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., Mark E.J., Lander E.S., Wong W., Johnson B.E., Golub T.R., Sugarbaker D.J., and Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13790-13795
79. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., Joshi M.B., Harpole D., Lancaster J.M., Berchuck A., Olson Jr. J.A., Marks J.R., Dressman H.K., West M., and Nevins J.R. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 (2006) 353-357
80. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., and Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13784-13789
81. Eom M., Han A., Yi S.Y., Shin J.J., Cui Y., and Park K.H. RHEB expression in fibroadenomas of the breast. Pathol. Int. 58 (2008) 226-232
82. Yamashita S., Nomoto T., Abe M., Tatematsu M., Sugimura T., and Ushijima T. Persistence of gene expression changes in stomach mucosae induced by short-term N-methyl-N'-nitro-N-nitrosoguanidine treatment and their presence in stomach cancers. Mutat. Res. 549 (2004) 185-193
83. Yovchev M.I., Grozdanov P.N., Joseph B., Gupta S., and Dabeva M.D. Novel hepatic progenitor cell surface markers in the adult rat liver. Hepatology 45 (2007) 139-149
84. Yovchev M.I., Grozdanov P.N., Zhou H., Racherla H., Guha C., and Dabeva M.D. Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 47 (2008) 636-647
85. Ruhe J.E., Streit S., Hart S., Wong C.H., Specht K., Knyazev P., Knyazeva T., Tay L.S., Loo H.L., Foo P., Wong W., Pok S., Lim S.J., Ong H., Luo M., Ho H.K., Peng K., Lee T.C., Bezler M., Mann C., Gaertner S., Hoefler H., Iacobelli S., Peter S., Tay A., Brenner S., Venkatesh B., and Ullrich A. Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Res. 67 (2007) 11368-11376
86. Nagarajan L., Louie E., Tsujimoto Y., Balduzzi P.C., Huebner K., and Croce C.M. The human c-ros gene (ROS) is located at chromosome region 6q16-6q22. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 6568-6572
87. Rabin M., Birnbaum D., Young D., Birchmeier C., Wigler M., and Ruddle F.H. Human ros1 and mas1 oncogenes located in regions of chromosome 6 associated with tumor-specific rearrangements. Oncogene Res. 1 (1987) 169-178
88. Satoh H., Yoshida M.C., Matsushime H., Shibuya M., and Sasaki M. Regional localization of the human c-ros-1 on 6q22 and flt on 13q12. Jpn J. Cancer Res. 78 (1987) 772-775
89. Shiffman D., Ellis S.G., Rowland C.M., Malloy M.J., Luke M.M., Iakoubova O.A., Pullinger C.R., Cassano J., Aouizerat B.E., Fenwick R.G., Reitz R.E., Catanese J.J., Leong D.U., Zellner C., Sninsky J.J., Topol E.J., Devlin J.J., and Kane J.P. Identification of four gene variants associated with myocardial infarction. Am. J. Hum. Genet. 77 (2005) 596-605
90. Zee R.Y., Michaud S.E., Hegener H.H., Diehl K.A., and Ridker P.M. A prospective replication study of five gene variants previously associated with risk of myocardial infarction. J. Thromb. Haemost. 4 (2006) 2093-2095
91. Horne B.D., Carlquist J.F., Muhlestein J.B., Nicholas Z.P., and Anderson J.L. Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study. Am. Heart J. 154 (2007) 969-975
92. Oguri M., Kato K., Hibino T., Yokoi K., Segawa T., Matsuo H., Watanabe S., Nozawa Y., Murohara T., and Yamada Y. Genetic risk for restenosis after coronary stenting. Atherosclerosis (2007)
93. Yamada Y., Kato K., Yoshida T., Yokoi K., Matsuo H., Watanabe S., Ichihara S., Metoki N., Yoshida H., Satoh K., Aoyagi Y., Yasunaga A., Park H., Tanaka M., and Nozawa Y. Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals. Int. J. Mol. Med. 21 (2008) 83-89
94. Garber E.A., Hanafusa T., and Hanafusa H. Membrane association of the transforming protein of avian sarcoma virus UR2 and mutants temperature sensitive for cellular transformation and protein kinase activity. J. Virol. 56 (1985) 790-797
95. Chan J.L., Lai M., and Wang L.H. Effect of dimerization on signal transduction and biological function of oncogenic Ros, insulin, and insulin-like growth factor I receptors. J. Biol. Chem. 272 (1997) 146-153
96. Zong C.S., and Wang L.H. Modulatory effect of the transmembrane domain of the protein-tyrosine kinase encoded by oncogene ros: biological function and substrate interaction. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 10982-10986
97. Xiong Q., Chan J.L., Zong C.S., and Wang L.H. Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth. Mol. Cell Biol. 16 (1996) 1509-1518
98. Zong C.S., Poon B., Chen J., and Wang L.H. Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros. J. Virol. 67 (1993) 6453-6462
99. Murer H., Forster I., and Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch. 447 (2004) 763-767
100. Lambert G., Traebert M., Hernando N., Biber J., and Murer H. Studies on the topology of the renal type II NaPi-cotransporter. Pflugers Arch. 437 (1999) 972-978
101. Hilfiker H., Hattenhauer O., Traebert M., Forster I., Murer H., and Biber J. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14564-14569
102. Feild J.A., Zhang L., Brun K.A., Brooks D.P., and Edwards R.M. Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine. Biochem. Biophys. Res. Commun. 258 (1999) 578-582
103. Xu H., Collins J.F., Bai L., Kiela P.R., and Ghishan F.K. Regulation of the human sodium-phosphate cotransporter NaP(i)-IIb gene promoter by epidermal growth factor. Am. J. Physiol. Cell Physiol. 280 (2001) C628-636
104. Traebert M., Hattenhauer O., Murer H., Kaissling B., and Biber J. Expression of type II Na-P(i) cotransporter in alveolar type II cells. Am. J. Physiol. 277 (1999) L868-873
105. Leng L., Metz C.N., Fang Y., Xu J., Donnelly S., Baugh J., Delohery T., Chen Y., Mitchell R.A., and Bucala R. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197 (2003) 1467-1476
106. Badve S., Deshpande C., Hua Z., and Logdberg L. Expression of invariant chain (CD 74) and major histocompatibility complex (MHC) class II antigens in the human fetus. J. Histochem. Cytochem. 50 (2002) 473-482
107. Lazova R., Moynes R., May D., and Scott G. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 79 (1997) 2115-2124
108. Ong G.L., Goldenberg D.M., Hansen H.J., and Mattes M.J. Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines. Immunology 98 (1999) 296-302
109. Datta M.W., Shahsafaei A., Nadler L.M., Freeman G.J., and Dorfman D.M. Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms. Appl. Immunohistochem. Mol. Morphol. 8 (2000) 210-215
110. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Iwashige H., Aridome K., Hokita S., and Aikou T. Invariant chain expression in gastric cancer. Cancer Lett. 168 (2001) 87-91
111. Young A.N., Amin M.B., Moreno C.S., Lim S.D., Cohen C., Petros J.A., Marshall F.F., and Neish A.S. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 158 (2001) 1639-1651
112. Burton J.D., Ely S., Reddy P.K., Stein R., Gold D.V., Cardillo T.M., and Goldenberg D.M. CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin. Cancer Res. 10 (2004) 6606-6611
113. Hustinx S.R., Cao D., Maitra A., Sato N., Martin S.T., Sudhir D., Iacobuzio-Donahue C., Cameron J.L., Yeo C.J., Kern S.E., Goggins M., Mollenhauer J., Pandey A., and Hruban R.H. Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression. Cancer Biol. Ther. 3 (2004) 1254-1261
114. Rangel L.B., Agarwal R., Sherman-Baust C.A., Mello-Coelho V., Pizer E.S., Ji H., Taub D.D., and Morin P.J. Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers. Cancer Biol. Ther. 3 (2004) 1021-1027
115. Cooper T.G. Sperm maturation in the epididymis: a new look at an old problem. Asian J. Androl. 9 (2007) 533-539
116. Britan A., Lareyre J.J., Lefrancois-Martinez A.M., Manin M., Schwaab V., Greiffeuille V., Vernet P., and Drevet J.R. Spontaneously immortalized epithelial cells from mouse caput epididymidis. Mol. Cell Endocrinol. 224 (2004) 41-53
117. Cooper T.G., Wagenfeld A., Cornwall G.A., Hsia N., Chu S.T., Orgebin-Crist M.C., Drevet J., Vernet P., Avram C., Nieschlag E., and Yeung C.H. Gene and protein expression in the epididymis of infertile c-ros receptor tyrosine kinase-deficient mice. Biol. Reprod. 69 (2003) 1750-1762
118. Cooper T.G., Yeung C.H., Wagenfeld A., Nieschlag E., Poutanen M., Huhtaniemi I., and Sipila P. Mouse models of infertility due to swollen spermatozoa. Mol. Cell Endocrinol. 216 (2004) 55-63
119. Yeung C.H., Anapolski M., Setiawan I., Lang F., and Cooper T.G. Effects of putative epididymal osmolytes on sperm volume regulation of fertile and infertile c-ros transgenic Mice. J. Androl. 25 (2004) 216-223
120. Yeung C.H., Breton S., Setiawan I., Xu Y., Lang F., and Cooper T.G. Increased luminal pH in the epididymis of infertile c-ros knockout mice and the expression of sodium-hydrogen exchangers and vacuolar proton pump H+-ATPase. Mol. Reprod. Dev. 68 (2004) 159-168
121. Yeung C.H., and Cooper T.G. Developmental changes in signalling transduction factors in maturing sperm during epididymal transit. Cell Mol. Biol. (Noisy-le-grand) 49 (2003) 341-349
122. Keilhack H., Muller M., Bohmer S.A., Frank C., Weidner K.M., Birchmeier W., Ligensa T., Berndt A., Kosmehl H., Gunther B., Muller T., Birchmeier C., and Bohmer F.D. Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1. J. Cell Biol. 152 (2001) 325-334
123. Bignon J.S., and Siminovitch K.A. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. Immunopathol. 73 (1994) 168-179
124. Kozlowski M., Mlinaric-Rascan I., Feng G.S., Shen R., Pawson T., and Siminovitch K.A. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178 (1993) 2157-2163
125. Neel B.G., Gu H., and Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28 (2003) 284-293
126. Wang N., Li Z., Ding R., Frank G.D., Senbonmatsu T., Landon E.J., Inagami T., and Zhao Z.J. Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling. J. Biol. Chem. 281 (2006) 21878-21883
127. Ellis L., Morgan D.O., Jong S.M., Wang L.H., Roth R.A., and Rutter W.J. Heterologous transmembrane signaling by a human insulin receptor-v-ros hybrid in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 5101-5105
128. Sachs M., Weidner K.M., Brinkmann V., Walther I., Obermeier A., Ullrich A., and Birchmeier W. Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J. Cell Biol. 133 (1996) 1095-1107
129. Zeng L., Sachdev P., Yan L., Chan J.L., Trenkle T., McClelland M., Welsh J., and Wang L.H. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol. Cell Biol. 20 (2000) 9212-9224
130. Zong C.S., Chan J.L., Yang S.K., and Wang L.H. Mutations of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation. J. Biol. Chem. 272 (1997) 1500-1506
131. Choong K., Freedman M.H., Chitayat D., Kelly E.N., Taylor G., and Zipursky A. Juvenile myelomonocytic leukemia and Noonan syndrome. J. Pediatr. Hematol. Oncol. 21 (1999) 523-527
132. Tartaglia M., and Gelb B.D. NOONAN SYNDROME AND RELATED DISORDERS: Genetics and Pathogenesis. Annu. Rev. Genomics Hum. Genet. 6 (2005) 45-68
133. Loh M.L., Vattikuti S., Schubbert S., Reynolds M.G., Carlson E., Lieuw K.H., Cheng J.W., Lee C.M., Stokoe D., Bonifas J.M., Curtiss N.P., Gotlib J., Meshinchi S., Le Beau M.M., Emanuel P.D., and Shannon K.M. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103 (2004) 2325-2331
134. Tartaglia M., Martinelli S., Cazzaniga G., Cordeddu V., Iavarone I., Spinelli M., Palmi C., Carta C., Pession A., Arico M., Masera G., Basso G., Sorcini M., Gelb B.D., and Biondi A. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood 104 (2004) 307-313
135. Tartaglia M., Niemeyer C.M., Fragale A., Song X., Buechner J., Jung A., Hahlen K., Hasle H., Licht J.D., and Gelb B.D. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34 (2003) 148-150
136. Tartaglia M., Niemeyer C.M., Shannon K.M., and Loh M.L. SHP-2 and myeloid malignancies. Curr. Opin. Hematol. 11 (2004) 44-50
137. Bentires-Alj M., Paez J.G., David F.S., Keilhack H., Halmos B., Naoki K., Maris J.M., Richardson A., Bardelli A., Sugarbaker D.J., Richards W.G., Du J., Girard L., Minna J.D., Loh M.L., Fisher D.E., Velculescu V.E., Vogelstein B., Meyerson M., Sellers W.R., and Neel B.G. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64 (2004) 8816-8820
138. Mohi M.G., Williams I.R., Dearolf C.R., Chan G., Kutok J.L., Cohen S., Morgan K., Boulton C., Shigematsu H., Keilhack H., Akashi K., Gilliland D.G., and Neel B.G. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7 (2005) 179-191
139. Bennett A.M., Hausdorff S.F., O'Reilly A.M., Freeman R.M., and Neel B.G. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol. Cell Biol. 16 (1996) 1189-1202
140. Noguchi T., Matozaki T., Horita K., Fujioka Y., and Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol. Cell Biol. 14 (1994) 6674-6682
141. Saxton T.M., Ciruna B.G., Holmyard D., Kulkarni S., Harpal K., Rossant J., and Pawson T. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Nat. Genet. 24 (2000) 420-423
142. Shi Z.Q., Yu D.H., Park M., Marshall M., and Feng G.S. Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Mol. Cell Biol. 20 (2000) 1526-1536
143. Yamauchi K., Milarski K.L., Saltiel A.R., and Pessin J.E. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 664-668
144. Zhan Y., and O'Rourke D.M. SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival. Cancer Res. 64 (2004) 8292-8298
145. Barford D., and Neel B.G. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure 6 (1998) 249-254
146. Neel B.G., and Tonks N.K. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 9 (1997) 193-204
147. Jarvis L.A., Toering S.J., Simon M.A., Krasnow M.A., and Smith-Bolton R.K. Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases. Development 133 (2006) 1133-1142
148. Nguyen K.T., Zong C.S., Uttamsingh S., Sachdev P., Bhanot M., Le M.T., Chan J.L., and Wang L.H. The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation. J. Biol. Chem. 277 (2002) 11107-11115
149. Engelman J.A., Luo J., and Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7 (2006) 606-619
150. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
151. Fresno Vara J.A., Casado E., de Castro J., Cejas P., Belda-Iniesta C., and Gonzalez-Baron M. PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev. 30 (2004) 193-204
152. Osaki M., Oshimura M., and Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9 (2004) 667-676
153. Altomare D.A., and Testa J.R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 24 (2005) 7455-7464
154. Plas D.R., and Thompson C.B. Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24 (2005) 7435-7442
155. Ruggero D., and Sonenberg N. The Akt of translational control. Oncogene 24 (2005) 7426-7434
156. Testa J.R., and Tsichlis P.N. AKT signaling in normal and malignant cells. Oncogene 24 (2005) 7391-7393
157. Uttamsingh S., Zong C.S., and Wang L.H. Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 Is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts. J. Biol. Chem. 278 (2003) 18798-18810
158. Dasgupta B., Yi Y., Chen D.Y., Weber J.D., and Gutmann D.H. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res. 65 (2005) 2755-2760
159. Haas-Kogan D., Shalev N., Wong M., Mills G., Yount G., and Stokoe D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol. 8 (1998) 1195-1198
160. Holland E.C., Celestino J., Dai C., Schaefer L., Sawaya R.E., and Fuller G.N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25 (2000) 55-57
161. Hu X., Pandolfi P.P., Li Y., Koutcher J.A., Rosenblum M., and Holland E.C. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7 (2005) 356-368
162. Buettner R., Mora L.B., and Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8 (2002) 945-954
163. Klampfer L. Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Curr. Cancer Drug Targets 6 (2006) 107-121
164. Frank D.A. StAT signaling in cancer: insights into pathogenesis and treatment strategies. Cancer Treat Res. 115 (2003) 267-291
165. Frank D.A. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 251 (2007) 199-210
166. Mizoguchi M., Betensky R.A., Batchelor T.T., Bernay D.C., Louis D.N., and Nutt C.L. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J. Neuropathol. Exp. Neurol. 65 (2006) 1181-1188
167. Zong C.S., Zeng L., Jiang Y., Sadowski H.B., and Wang L.H. Stat3 plays an important role in oncogenic Ros- and insulin-like growth factor I receptor-induced anchorage-independent growth. J. Biol. Chem. 273 (1998) 28065-28072
168. Schmitz A.A., Govek E.E., Bottner B., and Van Aelst L. Rho GTPases: signaling, migration, and invasion. Exp. Cell Res. 261 (2000) 1-12
169. Hornstein I., Alcover A., and Katzav S. Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16 (2004) 1-11
170. Aznar S., Fernandez-Valeron P., Espina C., and Lacal J.C. Rho GTPases: potential candidates for anticancer therapy. Cancer Lett. 206 (2004) 181-191
171. Titus B., Schwartz M.A., and Theodorescu D. Rho proteins in cell migration and metastasis. Crit. Rev. Eukaryot Gene Expr. 15 (2005) 103-114
172. Bao R., and Friedrich M. Fast co-evolution of sevenless and bride of sevenless in endopterygote insects. Dev. Genes Evol. 218 (2008) 215-220
173. Robbins M.J., Michalovich D., Hill J., Calver A.R., Medhurst A.D., Gloger I., Sims M., Middlemiss D.N., and Pangalos M.N. Molecular cloning and characterization of two novel retinoic acid-inducible orphan G-protein-coupled receptors (GPRC5B and GPRC5C). Genomics 67 (2000) 8-18
174. Brauner-Osborne H., and Krogsgaard-Larsen P. Sequence and expression pattern of a novel human orphan G-protein-coupled receptor, GPRC5B, a family C receptor with a short amino-terminal domain. Genomics 65 (2000) 121-128
175. Robbins M.J., Charles K.J., Harrison D.C., and Pangalos M.N. Localisation of the GPRC5B receptor in the rat brain and spinal cord. Brain Res. Mol. Brain Res. 106 (2002) 136-144
176. Imanishi S., Sugimoto M., Morita M., Kume S., and Manabe N. Changes in expression and localization of GPRC5B and RARalpha in the placenta and yolk sac during middle to late gestation in mice. J. Reprod. Dev. 53 (2007) 1131-1136
177. Avram C., Yeung C.H., Nieschlag E., and Cooper T.G. Regulation of the initial segment of the murine epididymis by dihydrotestosterone and testicular exocrine secretions studied by expression of specific proteins and gene expression. Cell Tissue Res. 317 (2004) 13-22